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Abstract: A novel pathogen, named SARS-CoV-2, has caused an unprecedented worldwide pandemic in the first half of 2020. As the
SARS-CoV-2 genome sequences have become available, one of the important focus of scientists has become tracking variations in the
viral genome. In this study, 30366 SARS-CoV-2 isolate genomes were aligned using the software developed by our group (ODOTool)
and 11 variations in SARS-CoV-2 genome over 10% of whole isolates were discussed. Results indicated that, frequency rates of these 11
variations change between 3.56%–88.44 % and these rates differ greatly depending on the continents they have been reported. Despite
some variations being in low frequency rate in some continents, C14408T and A23403G variations on Nsp12 and S protein, respectively,
observed to be the most prominent variations all over the world, in general, and both cause missense mutations. It is also notable that
most of isolates carry C14408T and A23403 variations simultaneously and also nearly all isolates carrying the G25563T variation
on ORF3a, also carry C14408T and A23403 variations, although their location distributions are not similar. All these data should be
considered towards development of vaccine and antiviral treatment strategies as well as tracing diversity of virus in all over the world.
Key words: SARS-CoV-2, COVID-19, genomic diversity, codon bias, multiple sequence alignment

1. Introduction
COVID-19 (novel COronaVIrus Disease 2019) is caused
by a novel pathogen that is pursued closely by all over the
world after the worldwide pandemic was declared by WHO
on March 11th. It has become one of the most important
health problems by causing nearly 5M confirmed cases and
over 300K deaths from 213 countries/regions in a couple
of months (WHO, 2020a)1. More than 17,000 papers by the
query “COVID-19” indexed in PubMed/NCBI and nearly
200 of them, as of 29th May 2020, about genome of severe
acute respiratory syndrome-COronaVirus-2 (SARSCoV-2) which is the agent responsible for the disease.
1.1. Taxonomy of SARS-CoV-2
SARS-CoV-2, is an enveloped, +ssRNA virus belonging
to the Coronaviridae family that are classified into 4
major genera: Alphacoronavirus, Betacoronavirus,
Gammacoronavirus,
and
Deltacoronavirus
by
phylogenetic studies and classified in the Betacoronavirus
genus, Sarbecovirus and grouped as SARS-Like CoVs
(Gorblenya et al., 2020). CoVs can infect many of animal
WHO (2020a). Coronavirus disease (COVID-2019) situation reports. [online]. Website: https://www.who.int/emergencies/diseases/
novel-coronavirus-2019/situation-reports accessed 17 May 2020].
1

species from different genus including mammals, avians
and reptiles (Gorblenya et al., 2006; Wu et al., 2020;
Gorblenya et al., 2020). Until December 2019, there were
6 coronavirus species known as human pathogen. Four
of them (229E, OC43, NL63, and HKU1) have caused
common cold and others 2 worldwide outbreaks (SARS
2003; MERS 2012) over the last 20 years (Su et al., 2016;
Zhu et al., 2020). Recently, a 7th coronavirus species has
been discovered in December 2019 and first named as
2019 novel Coronavirus (2019 nCoV) and then as SARSCoV-2 (Gorblenya et al., 2020).
1.2. The outbreaks of CoVs
An outbreak of severe acute respiratory syndrome (SARS)
was reported in November 2002. Despite patients carried
symptoms of a viral infection, no pathogen causing
pneumonia was identified, and in a few months, it was
revealed that a novel CoV had caused this syndrome (Peiris
et al., 2003). The filiation studies about SARS showed that
the early cases were mostly seen among restaurant workers
in Guandong Province, China and this information led
researchers to suspect that transmission source of the
virus might be an animal like bat or civet, that frequently
consumed in that province (Zhong et al., 2003; Guan et
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al., 2003; Su et al., 2016). This was the first-known CoV
outbreak that caused 8096 cases and 774 deaths in 37
countries or areas until July 2003 (WHO, 2004)2.
In the summer of 2012, 9 years after SARS outbreak
was controlled, a novel coronavirus disease called Middle
East Respiratory Syndrome (MERS) was reported in Saudi
Arabia (WHO, 2019)3. A 60-year-old man with severe fever
and cough, was diagnosed as pneumoniae and, as in SARS,
no pathogen causing pneumonia was detected, however,
fragments that amplified from some of PCR assays for the
detection of coronaviruses were sequenced and analysis of
the results indicated a novel coronavirus named MERSCoV relative with HKU4 and HKU5 (Zaki et al., 2012; de
Groott al., 2013; Yin and Wunderink, 2013). Despite the
transmission from animal to human has not been clearly
verified, the dromedary camels have been proposed as the
main reservoir host for the virus (Azhar et al., 2014; WHO,
2019). This epidemic was mostly effective in Saudi Arabia
and in the gulf countries, caused nearly 2500 confirmed
cases with 35% death rate (WHO, 2019).
Transmission mechanism of both SARS-CoV and
MERS-CoV from animal to human was reported to be
the direct contact with host animals or consumption
of raw milk, meat or urine (Yin and Wunderink, 2013;
WHO, 2019). The studies listed the 3 major causes of
SARS epidemic termination: the public health strategies,
scientific development in biology and medicine, and
hygiene practices (Chew, 2007).
1.3. Evolution of SARS-CoV-2
It was already known that the Spike (S) glycoprotein
plays a determining role in CoV infections (Sanchez et
al., 1999) and is effective in viral entry and pathogenesis
(Gallagher and Buchmeiert, 2001). During the ongoing
SARS outbreak, it has been discovered that the novel virus
has developed a new viral entry mechanism by binding
S protein to angiotensin-converting enzyme 2 (ACE2)
receptors (Li et al., 2003), as the identification mark of
SARS-CoV adaptation which has been caused by the
mutations on S protein residues between 318–510 that
named as receptor binding protein (RBD) (Wong et al.,
2004; Li et al., 2005). After the SARS outbreak, animals
such as bats, civets, and pangolins, have been seen as the
main reservoir hosts of the SARS-related CoVs that has
similar entry mechanism and scientists have focused on
2
WHO (2004). Summary of probable SARS cases with onset of illness
from 1 November 2002 to 31 July 2003. [online]. Website: https://
www.who.int/csr/sars/country/table2004_04_21/en/ [accessed 17
May 2020].
3
WHO (2019). Middle East respiratory syndrome coronavirus
(MERS-CoV). [online]. Website: https://www.who.int/en/newsroom/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov) [accessed 17 May 2020].
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studying viruses hosted by these animals (Ge et al., 2013;
Li, 2016; Cui et al., 2019; Liu et al., 2019). Despite RBD
of MERS-CoV-2 binds to dipeptidyl peptidase 4 (Raj et
al.,2013), it has been revealed that RBD of SARS-CoV-2
binds ACE2, like in SARS-CoV (Tai et al., 2020). Although
it has been lasted about 1 year to resolve this mechanism
for the SARS-CoV (Li et al., 2003), this timing was much
shorter, as nearly 3 months, with the research ability that
have been gained with the developing DNA sequencing
technologies and over years of experience in this area (Tai
et al., 2020; Ou et al., 2020).
1.4. Genomic studies on CoVs
There are more than 7,000 complete genome entry
uploaded to Nucleotide/NCBI databases from
Coronaviridae family between 2002–2020, more than half
of them is being SARS-CoV-2 (www.ncbi.nlm.nih.gov/
nuccore/, accessed 29th May 2020) and it is increasing
in parallel to the development of sequencing technology.
The coronavirus genome structure has been characterised
by various studies (Kocherhans et al., 2001; Brian and
Baric, 2005; Gorblenya et al., 2006; Yang and Leibowitz,
2015; Madhugiri et al., 2016) with the genome size
around 30kb. CoVs are referred to have the largest known
genome size among RNA viruses (Brian and Baric, 2005).
All CoV genomes contain a large gene region (named
ORF) encoding nonstructural proteins (Nsp) which are
responsible for mostly replication and the genes encoding
spike (S) glycoprotein, envelope (E) protein, membrane
(M) glycoprotein and nucleocapsid (N) protein have also
been found in common (Brian and Baric, 2005; Gorblenya
et al., 2006).
The genome sequence of SARS-CoV-2 was first
characterised by Wu et al. in December 2019 (Wu et al,
2020) and appointed as reference genome of SARS-CoV-2
(NC_045512.2; 1-29870); consist of 11 gene regions;
ORF1ab (266-21555), S (21563-25384), ORF3a (2539326220), E (26245-26472), M (26523-27191), ORF6 (2720227387), ORF7a (27394-27759), ORF7b (27756-27887),
ORF8 (27894-28259), N (8274-29533), ORF10 (2955829674) by NCBI (Genbank, 2020).
Although this reference genome sequence is commonly
used in most studies, it is extremely important to monitor
the variations in the virus genome to understand the
evolution and spread of the virus and also to use this
information in the development possible treatments
and vaccines accordingly. For this purpose, GISAID
(GISAID, 2020; Elbe and Buckland-Merrett, 2017; Shu,
and McCauley, 2017) which collects and shares genome
sequences and related clinical/epidemiological data
for monitoring annual influenza strains, established a
new database called EpiCoV and the first SARS-CoV-2
genome was shared on 10th January 2020. More than
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30,000 genome sequences of SARS-CoV-2 were uploaded
to EpiCoV databases between 10th January and 20th May
2020 (EpiCoV, 2020)4.
In this study; we have used these data to analyse the
mutations on SARS-CoV-2 genome using a software based
on multiple sequence alignment (Strategy Based Local
Alignment Tool: ODOTool) that have been originally
developed for bacterial SNP determination in our studies.
Now, we targeted to analyse the mutations that have
emerged in at least 10% of SARS-CoV-2 genomes in all
30366 sequences submitted in GISAID by May 20th, 2020
using the ODOTool in terms of date and location they
occurred, the relationship with each other and their effect
on the primary protein structure.
2. Materials and methods
2.1. Data optimization and development of strategy
based local alignment tool: ODOTool
Despite the Strategy Based Local Alignment Tool
(ODOTool) used in this study was originally developed by
our group for bacterial single nucleotide polymorphism
(SNP) determination, it was reasonable to test the abilities
of the tool using a different dataset with the emergence
of SARS-CoV-2 causing COVID-19 pandemic and this is
applied in the present study to analyse variations in viral
genome.
The first genome sequence of SARS-CoV-2 has been
identified and submitted with the accession number of
MN908947.1 to Genbank by Wu et al. in December 2020
(Wu et al., 2020), then curated by NCBI staff, reviewed
by RefSeq (O’Leary et al., 2015), and appointed as the
reference genome of SARS-CoV-2 (NC_045512.2)
(Genbank, 2020). Genomic sequences (30366) of SARSCoV-2 isolates submitted on GISAID/ EpiCoV database
by 21st May 2020, have been downloaded in FASTA file
format, into our local database for alignment and analysis.
Workflow of ODOTool is given in Figure 1. The main
purpose of developing the ODOTool was analysing bacterial
gene sequences for single nucleotide polymorphism (SNP)
determination. It was designed to download bulk data
of gene sequences from open access databases such as
Genbank/NCBI and EMBL-EBI, to prepare data first for
prealignment and then for alignment and analysis of the
aligned sequences. Prealignment and generating universal
consensus sequences module (shown in grey in Figure 1)
is an additional step for analysis of the sequences among
different genus, hence it is not used in the present study.
The ODOTool has been coded with Python
programming language by Biophyton library (Cock et al.,
EpiCoV (2020). Pandemic coronavirus causing COVID-19 [online].
Website: https://www.epicov.org/ [accessed 17 May 2020].
4

2009). After the genome sequence downloading process,
all data were stored in our local database with annotations
such as isolate name, location, collection, and submission
dates etc. The data downloaded from different databases
were not in a standard format. Therefore, an additional
data conversion step was applied to remove any undesired
features or information like FASTA comments, line feeds,
blank spaces and all sequences set to upper cases etc. to
standardise all data prior to further analyses. Modified
Needleman-Wunsch algorithm, modified BLOSUM 62
scoring matrix and adjusted gap penalties (match = 4,
mismatch = –1, reference genome open gap score = –1000,
reference genome extend gap score = –1000, isolate genome
open gap score = –20, isolate genome extend gap score
= –4) were used for alignment step. Aligned nucleotide
sequences were then converted to protein sequences to
determine missense mutations using standard codon
table (Peabody, 1989). Aligned nucleotide and protein
sequences of all downloaded isolate genomes were stored
in local database for computational, visual, and statistical
analysis.
The alignments performed by ODOTool were validated
with multiple alignment program MAFFT v7 (Kuraku et
al., 2013; Katoh et al., 2017) to evaluate the accuracy and
performance of ODOTool. Data size suggested for accuracy
by MAFFT v7 is 200 genome sequences . Therefore, 200
SARS-CoV-2 genomes were randomly selected and the
same sequences were analysed by using both MAFFT v7
and ODOTool. The genomic positions and frequencies
of variations were compared for validation. The genomic
positions of variations were determined by homology and
frequencies were calculated by Jalview v2.10.5 consensus
calculation algorithm (Waterhause et al., 2009).
2.2. Mutation analysis
Alignment results obtained using the software developed
in this study were verified with the Nextstrain platform
(Hadfield, 2018; Nextstrain, 20205) that has been created
to monitor virus evolution in real time. In this study,
occupancy of sequences in alignment were considered in
calculation of variation frequencies. Variations occurring
over 10% frequency in clinical isolate genomes that have
been downloaded into our database were evaluated and
discussed specific to the genes. It must be noted that
availability of these variations is also previously reported
in other studies (Nextstrain, 2020; Pachetti et al., 2020;
Wang et al., 2020; Phan et al., 2020) with different aspects.
Despite the variations occurring over 10% frequency
were discussed in the present study, it was noticed that
SARS-CoV-2 isolate genomes were harbouring some of
NextStrain (2020). Nextstrain: analysis and visualization of pathogen sequence data [online] Website: https://nextstrain.org/ [ accessed 17 May 2020].
5
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Figure 1. Workflow of ODOTool.

the variations over 20% frequency and causing missense
mutations and so focused on these mutations in more
detail and some charts were produced to show increasing
EpiCoV entries, rate changes of the most frequent changes
and rates of the most frequent mutations by continents.
The isolates with mistyped location and date
annotations, nearly 2–3% of all downloaded entries, were
ignored, while charts were created. Venn diagram presents
simultaneously carried mutations and has been generated
by Jvenn web tool (Bardou et al., 2014).
3. Results and discussion
3.1. Data optimization and development of Strategy
Based Local Alignment tool: ODOTool
The alignments of randomly selected 200 SARS-CoV-2
isolate genome sequences were evaluated for validation
according to genomic positions and frequencies of
variations. It is well known that different datasets
produce different results. As seen on Table 1, frequency
calculation result by using both tools on the same dataset
are consistent, showing validity of the results obtained
by using the ODOTool. Further technical properties of
ODOTool is excluded as these details are out of this Special
Issue’s scopes.
In this study, 30366 SARS-CoV-2 isolate genome
sequences were downloaded, standardised, aligned and
in silico protein translation was performed. All processed
data stored in a database for analysis.
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3.2. Mutation analysis
When the variations on SARS-CoV-2 genome is
evaluated in general, several uneven used synonymous
codons encode most of amino acids and this situation
was defined as codon usage bias (CUB) that could have
specific causes and consequences in different organisms
(Belalov and Lukashev, 2013). CUB was explained by 2
primary circumstances; translational selection that means
choosing the most suitable codon for translation and
mutational pressure being gained by distinct probability of
different substitution types like GC content, deoxycytidine
methylation (C-phosphate-G), or subsequent deamination
(C-T substitution) (Bulmer, 1987; Sharp et al., 1993;
Belalov and Lukashev, 2013).
Cytosine deamination has been identified as an
important source of synonymous mutations (Duncan and
Miller, 1980) managing the GC contents of RNA viruses
(Pyrc et al., 2004). Because of cytosine deamination has
been observed in all coronavirus genomes and proposed
as a significant biochemical effect on coronavirus
evolution (Woo et al., 2007), it is a predictable result that
C-to T exchange has the most prominent numbers in all
nucleotide change directions in SARS-CoV-2 genome.
In this study, 11 variations, with the incidence of
over 10% have been detected in 30366 clinical SARSCoV-2 isolate genomes (Table 2). It has been observed
that 8 of these 11 variations; C1059T, G11083T, C14408T,
A23403G, G25563T, G28881A, G28882A, and G28883C
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Table 1. Comparison of variation frequency calculations
by ODOTool and MAFFT.

towards findings of these research studies with further
in vitro studies as its frequency rate is 70.99% in whole
genomes from all over the world.
Rest of the 10 variations on nonstructural, structural,
and accessory proteins are discussed below.

Reference
Frequency
Frequency
Nucleotide
genome
(calculated by (calculated by
exchange
position
ODOTool)
MAFFT)
241

C→T

77.0%

77.0%

1059

C→T

5.5%

5.5%

3037

C→T

82.5%

82.5%

11083

G→T

10.5%

10.5%

14408

C→T

82.5%

82.5%

14805

C→T

7.5%

7.5%

23403

A→G

82.0%

82.5%

25563

G→T

7.0%

7.0%

28881

G→A

58.0%

58.0%

28882

G→A

58.5%

58.5%

28883

G→C

58.5%

58.5%

cause amino acid substitutions. Three variations that do not
cause amino acid exchange were named as synonymous
mutations in the literature (Kimura, 1977).
When the 30366 SARS-CoV-2 genome sequences were
aligned, the first encountered variation was observed to
be C241T in the 5’ untranslated region (5’ UTR) being
occurred nearly in 70% of SARS-CoV-2 isolates. Studies
conducted on some viral genomes reported that the
variations on UTRs may affect the activity, replication,
and packaging of genomes, immune modulation and
expression of genes (Silveria et al., 1995; De Lorenzo et al.,
2016; Ng et al., 2017). This variation should be evaluated

3.2.1. Variations on nonstructural proteins
ORF1ab region of SARS-CoV-2 genome is an important
polyprotein gene common in all CoVs and encodes 16
Nsps that include enzymes vital for the lifecycle of the
virus, such as RNA depended polymerase, helicase and
3C-like proteinase (Brian and Baric, 2005; Gorblenya et
al., 2006). Because of the critical role of these proteins on
virulence and life cycle of the virus, some of these proteins
have been proposed as potential target for antiviral
therapy (Kwong et al., 2005; Briguglio et al., 2011; Zhou,
2020). Four variations over 10% were available on ORF1ab
region. The first variation C3037T causes a synonymous
mutation and seen in frequency of 29.3% in gene region
encoding Nsp3 that is an important unit of the replication/
transcription complex in CoVs (Lei et al., 2018). The other
3 variations, C1059T, G11083T, and C14408T causing
amino acid substitutions are in gene regions of Nsp2, Nsp6,
and Nsp12, respectively, in ORF1ab; with the incidence of
over 10%.
C1059T variation has been caused T266I amino acid
exchange on Nsp2. But it is difficult to evaluate the effect
of this exchange on the protein function, as the function
of Nsp2 has not been resolved yet (Graham et al., 2005;
Gadlage et al., 2008; Chen et al., 2020).
G11083T variation (reported previously by van Dorp
et al., 2020) causing L36F exchange was present on Nsp6
gene region that is known with its role in inducing vesicles

Table 2. Summary of variations evaluated in this article. Variations over 20% frequency are
shown in bold * synonymous mutations.
Genome position Nucleotide exchange Frequency Region

Amino acid exchange

241

C→T

70.99%

5’ UTR

-*

1059

C→T

18.10%

Nsp2/ORF1ab

T266I

3037

C→T

29.27%

Nsp3/ORF1ab

-*

11083

G→T

12.23%

Nsp6/ORF1ab

L36F

14408

C→T

70.42%

Nsp12/ORF1ab P323L

14805

C→T

10.01%

Nsp12/ORF1ab -*

23403

A→G

70.47%

S Protein

D614G

25563

G→T

22.49%

ORF3a

Q57H

28881

G→A

26.30%

N Protein

28882

G→A

26.13%

N Protein

28883

G→C

26.11%

N Protein

R204K
G205R
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located around the microtubule regulation centre and
ensuring membrane proliferation (Angelini et al., 2013).
This variation was suggested as a homoplastic mutation
(van Dorp et al., 2020) and suggested to be evaluated with
these characteristics in further studies.
C14408T (first reported by Pachetti et al., 2020) and
C14805T found to be present on Nsp12 gene region with
a frequency of 70.42% and 10.01% of isolates, respectively.
Nsp12 is a vital protein for replication and pathogenesis and
potential target for antiviral candidates in CoVs (Perlman
and Netland, 2009; Wu et al., 2020; Yin and Wunderink,
2018). C14408T variation observed to be responsible
from P323L exchange causing a missense mutation. The
isolate genome sequence harbouring C14408T variation
was first submitted to the GISAID from Lombardy, Italy,
on February 20th, 2020 (EPI_ISL_412973), 20 days after
the first COVID-19 case confirmed in Italy. Although
C14805T (submitted on February 9th, 2020 England; EPI_
ISL_412116) variation is rarer, it was emerged earlier than
C14408T variation. Despite C14408T variation occurred
later than C14805T, the incidence of this variation has
increased sharply and reach over 70%, recently (Figure 2).
This observation may be evaluated as a remarkable data
about the effect of C14408T variation on the spread of the
virus.
3.2.2 Variations on accessory and structural proteins
The increasing number of isolate genome entries in
EpiCoV and rate changes of the most frequent variations

by isolate collection dates are also given in Figure 2 for
G25563T variation on accessory protein and A23403G
variation on S protein and 3 consecutive variations
(G28881A, G28882A, and G28883C) named as GGG to
AAC on N protein.
G25563T variation is on the gene region of Orf3a
which is a unique membrane protein with its 3-membrane
structure, the largest protein in the SARS related
CoVs accessory protein family and is essential for the
pathogenesis of the disease (Lu et al., 2010; Issa et al.,
2020). G25560T variation also causes amino acid exchange
of glutamine to histidine in residue 57 (Q57H).
There are also 4 structural proteins named as Spike
(S), Envelope (E), Membrane (M), and Nucleocapsid (N)
proteins and all has been encoded in all CoV genomes,
including the SARS-CoV-2 (Brian and Baric, 2005;
Gorblenya et al., 2020). In the current study, 4 variations
were determined to cause amino acid substitutions in
regions encoding S and N proteins with an incidence of
over 10%.
A23403G variation is one of the most important
variations that have been reported previously (Phan et
al., 2020) caused D614G substitution on S protein. As in
the C14408T of Nsp12 variation, A23403G variation of
S protein is also available in 70.46% frequency in SARSCoV-2 genomes isolated all over the world (Figure 2).
S protein has important role in viral entry into the host
cells (Gallagher and Buchmeiert, 2001). Viral entry

Figure 2. The increasing EpiCoV entries and rate changes of the most frequent variations by isolate collection dates.
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and pathogenesis have been reported to be managed by
a couple of mutations in its RBD of S protein in SARSCoV (Wong et al., 2004; Li et al., 2005) aligned on residues
between 331 and 524 for SARS-CoV-2 (Tai et al., 2020; Ou
et al., 2020). RBD is located on the outer membrane of the
virus and these properties of RBD make the S protein a
suitable target for new treatment approaches (Tai et al.,
2020) and the most of the ongoing protein subunit vaccine
studies against SARS-CoV-2 (WHO, 2020b)6. Therefore,
any mutation on S protein of SARS-CoV-2 should be
carefully tracked and evaluated, as this protein is the
key target especially in the current vaccine development
studies (Kiyotani et al., 2020).
Perhaps one of the most interesting SARS-CoV-2
variations occurred between genomic positions of
28881–28883. The GGG sequence of reference SARSCoV-2 genome at these positions are converted to AAC
in nearly 26% of rest of the isolate genomes. These 3
variations (G28881A, G28882A and G28883C) were seen
simultaneously in about 99% of all isolates harbouring
the variations. G28881A and G28882A exchanges cause
R204K and G28883C exchange causes G205R amino acid
WHO (2020b). Draft landscape of COVID-19 candidate vaccines
[online]. Website: https://www.who.int/who-documents-detail/
draft-landscape-of-covid-19-candidate-vaccines accessed 17 May
2020].
6

substitutions on the N protein. N protein is an essential
structural protein, playing very different roles in the
regulation of infected cell metabolism and packaging
of the viral genome important for both replication and
transcription (Kang et al., 2020).
When the C14408T, G25563T, A23403G, and GGG to
AAC variations with over 20% frequency were analysed,
dramatic observations were seen in terms of appearance of
these mutations in different continents (Figure 3). Figure
3 clearly shows that; G25563T mutation is developed by
the isolates in N. America especially, GGG to AAC by the
isolates in Europe, the same mutation is rare in N. America.
C14408T and A23403G is common all over the world but
especially in Africa, then S. America and this is followed
by Europe (Figure 3). All these data could be used to trace
diversity of virus in all over the world in combination with
filiation studies.
Our mutation analysis revealed that most of the isolates
carry C14408T and A23403 variations simultaneously
(Figure 4) in all continents (Figure 3). Nearly all isolates
which carry G25563T, also carry C14408T and A23403G
variations although their location distributions are not
similar. Nearly no isolates carried GGG to AAC variations
and G25563T variation simultaneously (Figure 4). The
relation between these variations shown in Figure 4 may
indicate that these mutations are coevoluating. Therefore,

Figure 3. Rates of the most frequent variations by continents.
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Figure 4. SARS-CoV-2 isolate numbers carrying the variations Green: Isolate numbers carrying C14408T, Blue: Isolate
numbers carrying A23403G, Red: Isolate numbers carrying G25563T and Yellow: Isolate numbers carrying GGG to AAC
variations between 28881–28883.

these results should be followed and evaluated by affiliation
studies.
In conclusion; since the COVID-19 pandemic
emerged globally, all the world has been searching ways to
control the spread of the disease. As the virus’s adaptation
strategies come from its nature, scientists put a massive
effort on finding and development of suitable strategies for
both effective prevention and treatment and on monitoring
its virulence. Despite all these efforts, the virus continues
to survive and spread, and this necessitates tracking any
variations that occur on its genome to conduct further
studies to find a way to control the disease. SARS-CoV-2
isolate genomes (30366) were aligned using the Strategy
Based Local Alignment Tool (ODOTool) developed by our
group and 11 variations in SARS-CoV-2 genome observed
in over 10% of whole isolates from all over the world were
discussed according to the date and location they occurred,
the relationship with each other and their effect on the
primary protein structure in the present study. Data were
obtained as a result of evaluation of massive amount of
genomic sequences in this study and expected to enlighten
studies towards overcoming the SARS-CoV-2 infections.
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